Cargando…
The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are not specific to IBD, and are often seen in other inflammatory diseases, such as intestinal infections, drug-induced co...
Autores principales: | Alghoul, Zahra, Yang, Chunhua, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312796/ https://www.ncbi.nlm.nih.gov/pubmed/35884797 http://dx.doi.org/10.3390/biomedicines10071492 |
Ejemplares similares
-
Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome
por: Yang, Chunhua, et al.
Publicado: (2021) -
Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate
por: Yang, Chunhua, et al.
Publicado: (2022) -
Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles
por: Long, Dingpei, et al.
Publicado: (2023) -
Current status of image-enhanced endoscopy in inflammatory bowel disease
por: Yang, Young Joo
Publicado: (2023) -
Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016)